Urogen Pharma Ltd
NASDAQ:URGN

Watchlist Manager
Urogen Pharma Ltd Logo
Urogen Pharma Ltd
NASDAQ:URGN
Watchlist
Price: 10.71 USD 0.66% Market Closed
Market Cap: 452m USD
Have any thoughts about
Urogen Pharma Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Urogen Pharma Ltd

Current Assets 295.1m
Cash & Short-Term Investments 249.6m
Receivables 22.8m
Other Current Assets 22.7m
Non-Current Assets 6.8m
Long-Term Investments 4.6m
PP&E 1.7m
Other Non-Current Assets 545k
Current Liabilities 32.8m
Accounts Payable 5.6m
Accrued Liabilities 24m
Other Current Liabilities 3.2m
Non-Current Liabilities 243.6m
Long-Term Debt 121.7m
Other Non-Current Liabilities 121.9m

Balance Sheet
Urogen Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
4
18
21
37
101
50
53
44
55
95
Cash Equivalents
4
18
21
37
101
50
53
44
55
95
Short-Term Investments
0
0
0
36
0
97
49
45
45
42
Total Receivables
0
0
0
0
0
0
7
12
13
15
Accounts Receivables
0
0
0
0
0
0
7
12
13
15
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
2
5
4
6
Other Current Assets
0
1
1
1
1
2
5
9
12
11
Total Current Assets
4
19
22
75
102
149
116
114
129
169
PP&E Net
0
0
1
1
1
5
4
3
4
2
PP&E Gross
0
0
1
1
1
5
4
3
4
2
Accumulated Depreciation
0
0
0
1
1
1
1
2
3
4
Long-Term Investments
0
0
0
0
0
49
2
1
0
5
Other Long-Term Assets
0
0
0
0
0
1
0
2
3
2
Total Assets
4
N/A
19
+341%
23
+19%
76
+227%
104
+37%
202
+95%
122
-40%
120
-2%
136
+13%
178
+31%
Liabilities
Accounts Payable
1
2
2
3
4
5
3
6
6
7
Accrued Liabilities
0
1
1
4
9
15
18
14
16
22
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
1
1
0
0
1
2
2
3
Total Current Liabilities
1
2
3
7
14
20
21
22
24
31
Long-Term Debt
0
1
4
0
0
0
0
0
98
99
Other Liabilities
0
0
0
0
0
3
4
89
104
114
Total Liabilities
1
N/A
3
+158%
7
+116%
7
+4%
14
+93%
22
+64%
26
+16%
111
+333%
225
+102%
244
+8%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
13
25
27
47
123
228
357
467
577
679
Additional Paid In Capital
16
42
44
116
213
408
453
476
488
614
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
3
N/A
16
+409%
16
N/A
69
+320%
90
+32%
180
+100%
96
-47%
8
-91%
89
N/A
65
+27%
Total Liabilities & Equity
4
N/A
19
+341%
23
+19%
76
+227%
104
+37%
202
+95%
122
-40%
120
-2%
136
+13%
178
+31%
Shares Outstanding
Common Shares Outstanding
11
11
11
14
16
21
22
23
23
32

See Also

Discover More